Literature DB >> 11024547

Genetic control of pathogenic mechanisms in autoimmune demyelinating disease.

K A Sabelko-Downes1, M T Gimenez, G C Suvannavejh, S D Miller, J H Russell.   

Abstract

Multiple sclerosis is a disease of discrete phenotypes in different individuals. Animal models have been useful in identifying self-antigens that become the focus of autoimmune attack and genetic loci that control susceptibility to disease. We have previously demonstrated a role for Fas-dependent pathogenesis in the induction of EAE in B10.PL mice immunized with MBP. Others have indicated a Fas-independent mechanism predominates in SJL mice immunized with PLP. Here we compare the response of (B10.PLxSJL)F1 and parental mice under similar conditions for induction of EAE. The results indicate that immunodominance and dominant pathogenic mechanisms are both under genetic control, but can be inherited independently. The data also indicate that the dominant pathogenic mechanism can change during the course of disease in an individual. Elucidation of the genetic elements controlling pathogenesis during the course of disease would provide important information in designing therapeutic strategies for individuals in a heterogeneous patient population.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11024547     DOI: 10.1016/s0165-5728(00)00350-7

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  4 in total

1.  Substrain differences reveal novel disease-modifying gene candidates that alter the clinical course of a rodent model of multiple sclerosis.

Authors:  Leslie E Summers deLuca; Natalia B Pikor; Jennifer O'Leary; Georgina Galicia-Rosas; Lesley A Ward; Dustin Defreitas; Trisha M Finlay; Shalina S Ousman; Lucy R Osborne; Jennifer L Gommerman
Journal:  J Immunol       Date:  2010-02-19       Impact factor: 5.422

2.  Involvement of IFN-γ and perforin, but not Fas/FasL interactions in regulatory T cell-mediated suppression of experimental autoimmune encephalomyelitis.

Authors:  Tara Beeston; Trevor R F Smith; Igor Maricic; Xiaolei Tang; Vipin Kumar
Journal:  J Neuroimmunol       Date:  2010-08-12       Impact factor: 3.478

3.  Incomplete Killing And Enhanced Activation of Islet-Reactive CD8+ T Cells by FasL-Expressing Dendritic Cells Limits Protection from Diabetes.

Authors:  Mikael Maksimow; Catharina Alam; Arno Hänninen
Journal:  Rev Diabet Stud       Date:  2008-11-10

4.  A Novel Zinc Chelator, 1H10, Ameliorates Experimental Autoimmune Encephalomyelitis by Modulating Zinc Toxicity and AMPK Activation.

Authors:  Bo Young Choi; Jeong Hyun Jeong; Jae-Won Eom; Jae-Young Koh; Yang-Hee Kim; Sang Won Suh
Journal:  Int J Mol Sci       Date:  2020-05-10       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.